v3.23.1
Earnings Per Share (Tables)
 3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Schedule of basic and diluted earnings per share, impact of two-class method The following table summarizes the impact of the two-class method:
Three months ended
March 31,
(in millions, except per share data)20232022
Basic EPS
Net earnings attributable to AbbVie Inc.$239 $4,490 
Earnings allocated to participating securities11 22 
Earnings available to common shareholders$228 $4,468 
Weighted-average basic shares outstanding1,770 1,771 
Basic earnings per share attributable to AbbVie Inc.$0.13 $2.52 
Diluted EPS
Net earnings attributable to AbbVie Inc.$239 $4,490 
Earnings allocated to participating securities11 22 
Earnings available to common shareholders$228 $4,468 
Weighted-average shares of common stock outstanding1,770 1,771 
Effect of dilutive securities6 7 
Weighted-average diluted shares outstanding1,776 1,778 
Diluted earnings per share attributable to AbbVie Inc.$0.13 $2.51